ERIC VESSELS: Open Payments
NPI 1033351820 · GLASGOW, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$495 in 17 payments from 9 companies in 2025. Trend: 2023 $392 · 2024 $1,101 · 2025 $495
Food & beverage: $495
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 4 | $164 |
| ABBVIE INC. | 4 | $96 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $47 |
| SI-BONE, INC. | 1 | $45 |
| Stryker Corporation | 1 | $43 |
| Pacira Pharmaceuticals Incorporated | 1 | $35 |
| Averitas Pharma Inc. | 1 | $24 |
| Valinor Pharma, LLC | 1 | $22 |
| Globus Medical, Inc. | 1 | $18 |
Products named: PROCLAIM, BOTOX, RELISTOR, AUGMENT INJECTABLE, Zilretta, QUTENZA, MOVANTIK, Senza.
Industry payments across KY — which companies pay providers there.
